WebMar 18, 2024 · The BIOFIRE ® RP2.1 Panel allows healthcare providers to quickly identify common respiratory pathogens found in patients presenting with acute respiratory tract infection, using one simple test. WebThe product has been tested with the BioFire® FilmArray® system and provides the expected results, however performance characteristics must be established by the end user. ... 6 x 0.3 mL vials of RP2.1 Control 1 and 6 x 0.3 mL vials of RP2.1 Control 2; Intended Use. NATtrol products are ready-to-use, inactivated full process controls designed ...
BIOFIRE Respiratory 2.1-EZ Panel (EUA)* Pioneering …
WebThe BIOFIRE RP2.1-EZ Panel (EUA)* uses multiplex PCR technology to quickly and accurately identify a comprehensive menu of respiratory pathogens that can cause similar symptoms in patients suspected of SARS-CoV-2. Molecular testing is more sensitive than culture and more efficient than individual and send-out tests. WebBioFire RP2.1/RP2.1plus Positive control is composed of synthetic RNA transcripts specifically designed for and intended to be used solely with the BioFire RP2.1 assay and BioFire RP2.1plus assay. This product is not intended to replace manufacturer controls provided with the device. 6 Positive controls and 6 Negative controls. cycloplegics and mydriatics
BIOFIRE Respiratory Panels Pioneering Diagnostics
WebMay 4, 2024 · The BIOFIRE® RP2.1 test is the third molecular test from bioMérieux in response to the COVID-19 pandemic. The ARGENE® SARS-CoV-2 R-GENE® test and the BIOFIRE® COVID-19 test were launched in March. These three complementary tests help meet the varying needs of bioMérieux diverse customers and patients throughout the … WebRespiratory 2.1 (RP2.1) Panel. The FDA De Novo authorized BIOFIRE RP2.1 Panel is a frontline test to help clinicians quickly diagnose respiratory infections, including COVID … cyclopithecus